Studying a two-step liver surgery for liver cancer
Part of Cancer, Digestive system clinical trials.
This trial looks at a special two-step surgery called ALPPS for people with liver cancer that can't be removed in one operation. The first step helps the liver grow more healthy tissue, and then the second step removes the tumor. The goal is to understand how well this works and how the liver regenerates.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old
- You have a type of liver cancer (like hepatocellular carcinoma or cholangiocarcinoma) that needs the two-step ALPPS surgery
- Your liver function is good enough for a major surgery (doctors check this with blood tests and scores like Child-Pugh or MELD)
- Your tumors are in multiple parts of the liver or are complex, and your remaining liver after surgery would be too small without the first step
- You do not have cancer that has spread to other parts of your body that can't be removed (except for a few spots in the lungs that can be taken out)
- You are not pregnant or nursing
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study compares two ways of doing a staged liver surgery (ALPPS) to help regrow enough liver for people with certain liver cancers. It looks at outcomes and how well the remaining liver grows after surgery, using different surgical approaches.
This study tests whether combining two immunotherapy drugs (sintilimab and ipilimumab) with standard procedures to block or destroy the tumor's blood supply can help keep liver cancer from returning after surgery. It is for people whose liver cancer can be removed but has a higher risk of coming back.
This trial tests new treatment plans for people with advanced liver cancer that has worsened after initial therapy. The goal is to find more effective, personalized options based on how your cancer responds.
This trial tests a two-step surgery for colorectal cancer that has spread only to the liver. The goal is to remove all visible liver tumors by first dividing the liver and blocking blood flow to the diseased side, which helps the healthy side grow larger so it can be safely removed in a second surgery.
This trial studies a two-step liver transplant operation for people with hepatocellular carcinoma (a type of liver cancer) to improve outcomes compared with standard approaches. You may be screened with scans and blood tests to confirm your cancer is limited to the liver.
This trial tests a two-step liver surgery approach for people with advanced (not fully removable) liver cancer or end-stage liver disease, using chemotherapy first when applicable. The goal is to see if this staged plan can better control disease and allow safer surgery.
Hear when a new Hepato Cellular Carcinoma (HCC) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.